US Patent Issued to Acuitas Therapeutics on June 30 for "Lipids and lipid nanoparticle formulations for delivery of nucleic acids" (Canadian Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,627, issued on June 30, was assigned to Acuitas Therapeutics Inc. (Vancouver, Canada).

"Lipids and lipid nanoparticle formulations for delivery of nucleic acids" was invented by Steven M. Ansell (Vancouver, Canada) and Xinyao Du (Richmond, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds are provided having the following structure:or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R1, R2, R3, L1, L2, G1, G2 and G3 are as defined herein. Use of the compounds as a component of lipid nanoparticle formulations for delivery of a therapeutic agent, compositions comprising the compounds and methods for their use...